Marco Barbanti1, MD; Bernard Prendergast2, MD; Michael Haude3, MD; Nicolo Piazza4, MD; Stephan Windecker5, MD; Andreas Baumbach6, MD; Corrado Tamburino1*, MD, PhD
1. Policlinico-Vittorio Emanuele Hospital, University of Catania, Catania, Italy; 2. St Thomas’ Hospital, London, United Kingdom; 3. Städtische Kliniken Neuss, Lukaskrankenhaus GmbH, Neuss, Germany; 4. McGill University Health Center, Montreal, Canada; 5.
Welcome to London for the 10th edition of the world’s largest course focused on the exciting field of transcatheter therapies for valvular heart disease. Throughout the last decade, the course has evolved and expanded considerably, with a dynamic interactive programme provided by a global world-leading faculty and constantly renewed in response to invaluable feedback from over 2,500 course participants. Since the beginning, our constant purpose has been to provide the community with teaching and useful tools to improve the treatment of our patients affected by valvular heart disease.
As is the spirit of all PCR courses, this year ...